These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20044940)

  • 1. Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.
    Esmail LC; Phillips K; Kuek V; Cosio AP; Kohler JC
    BMC Int Health Hum Rights; 2010 Jan; 10():1. PubMed ID: 20044940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canada's implementation of the Paragraph 6 Decision: is it sustainable public policy?
    Cohen-Kohler JC; Esmail LC; Cosio AP
    Global Health; 2007 Dec; 3():12. PubMed ID: 18062821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The politics behind the implementation of the WTO Paragraph 6 Decision in Canada to increase global drug access.
    Esmail LC; Kohler JC
    Global Health; 2012 Apr; 8():7. PubMed ID: 22472291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canada and access to medicines in developing countries: intellectual property rights first.
    Lexchin J
    Global Health; 2013 Sep; 9():42. PubMed ID: 24007595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defending access to medicines in regional trade agreements: lessons from the Regional Comprehensive Economic Partnership - a qualitative study of policy actors' views.
    Townsend B
    Global Health; 2021 Jul; 17(1):78. PubMed ID: 34238347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Generates Attention to Health in Trade Policy-Making? Lessons From Success in Tobacco Control and Access to Medicines: A Qualitative Study of Australia and the (Comprehensive and Progressive) Trans-Pacific Partnership.
    Townsend B; Friel S; Schram A; Baum F; Labonté R
    Int J Health Policy Manag; 2021 Oct; 10(10):613-624. PubMed ID: 32610761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we expecting too much from print media? An analysis of newspaper coverage of the 2002 Canadian healthcare reform debate.
    Collins PA; Abelson J; Pyman H; Lavis JN
    Soc Sci Med; 2006 Jul; 63(1):89-102. PubMed ID: 16480808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lost in translation: the Canadian access to medicines regime from transnational activism to domestic implementation.
    Bubela T; Morin JF
    Health Law J; 2010; 18():113-57. PubMed ID: 22125973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canada's Access to Medicines Regime: Promise or Failure of Humanitarian Effort?
    Kohler JC; Lexchin J; Kuek V; Orbinski J
    Healthc Policy; 2010 Feb; 5(3):40-8. PubMed ID: 21286267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime.
    Weber A; Mills L
    Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Talking about a nanny nation: investigating the rhetoric framing public health debates in Australian news media.
    Chau JY; Kite J; Ronto R; Bhatti A; Bonfiglioli C
    Public Health Res Pract; 2019 Sep; 29(3):. PubMed ID: 31569205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation.
    Dreser A; Vázquez-Vélez E; Treviño S; Wirtz VJ
    BMC Public Health; 2012 Dec; 12():1051. PubMed ID: 23217185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobbying and nutrition policy in Canada: a quantitative descriptive study on stakeholder interactions with government officials in the context of Health Canada's Healthy Eating Strategy.
    Gaucher-Holm A; Mulligan C; L'Abbé MR; Potvin Kent M; Vanderlee L
    Global Health; 2022 May; 18(1):54. PubMed ID: 35619107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.
    Mhazo AT; Maponga CC
    BMC Health Serv Res; 2022 Nov; 22(1):1390. PubMed ID: 36419062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.
    Abelson J; Collins PA
    Healthc Policy; 2009 Feb; 4(3):e113-28. PubMed ID: 19377347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stakeholder Framing of Advertising Legislation: An Analysis of Media and Parliamentary Representations of the Loi Évin in the United Kingdom.
    Maani Hessari N; Knai C; Gallopel-Morvan K; Petticrew M; Landreat MG
    J Stud Alcohol Drugs; 2018 Jul; 79(4):532-538. PubMed ID: 30079867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The media and access issues: content analysis of Canadian newspaper coverage of health policy decisions.
    Rachul C; Caulfield T
    Orphanet J Rare Dis; 2015 Aug; 10():102. PubMed ID: 26303029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Framing of nutrition policy issues in the Australian news media, 2008-2018.
    Wise K; Cullerton K
    Aust N Z J Public Health; 2021 Oct; 45(5):491-496. PubMed ID: 34411381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panel: Canada's law on global access to affordable medicines.
    Avafia T; Morrison C; Clark B; Kohler JC
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):76-83. PubMed ID: 20225526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance.
    Vian T; Kohler JC; Forte G; Dimancesco D
    J Pharm Policy Pract; 2017; 10():18. PubMed ID: 28588896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.